DE69326461D1 - Verwendung von glyzerin zur dämpfung der transdermalen arzneimittelverabreichung - Google Patents

Verwendung von glyzerin zur dämpfung der transdermalen arzneimittelverabreichung

Info

Publication number
DE69326461D1
DE69326461D1 DE69326461T DE69326461T DE69326461D1 DE 69326461 D1 DE69326461 D1 DE 69326461D1 DE 69326461 T DE69326461 T DE 69326461T DE 69326461 T DE69326461 T DE 69326461T DE 69326461 D1 DE69326461 D1 DE 69326461D1
Authority
DE
Germany
Prior art keywords
drug
application
transdermal
delivery
glycerin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69326461T
Other languages
English (en)
Other versions
DE69326461T2 (de
Inventor
Werner Heiber
Charles Ebert
Dinesh Patel
Srinivasan Venkateshwaran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Actavis Laboratories UT Inc
Original Assignee
Theratech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theratech Inc filed Critical Theratech Inc
Publication of DE69326461D1 publication Critical patent/DE69326461D1/de
Application granted granted Critical
Publication of DE69326461T2 publication Critical patent/DE69326461T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00—Devices for applying media, e.g. remedies, on the human body

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69326461T 1992-06-11 1993-05-03 Verwendung von glyzerin zur dämpfung der transdermalen arzneimittelverabreichung Expired - Lifetime DE69326461T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89726992A 1992-06-11 1992-06-11
PCT/US1993/004152 WO1993025168A1 (en) 1992-06-11 1993-05-03 The use of glycerin in moderating transdermal drug delivery

Publications (2)

Publication Number Publication Date
DE69326461D1 true DE69326461D1 (de) 1999-10-21
DE69326461T2 DE69326461T2 (de) 2000-05-04

Family

ID=25407656

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69326461T Expired - Lifetime DE69326461T2 (de) 1992-06-11 1993-05-03 Verwendung von glyzerin zur dämpfung der transdermalen arzneimittelverabreichung

Country Status (13)

Country Link
EP (1) EP0644746B1 (de)
JP (1) JPH08501529A (de)
KR (1) KR950701508A (de)
AT (1) ATE184473T1 (de)
AU (1) AU677206B2 (de)
CA (1) CA2135925C (de)
DE (1) DE69326461T2 (de)
DK (1) DK0644746T3 (de)
ES (1) ES2137993T3 (de)
GR (1) GR3031246T3 (de)
HU (1) HU221598B (de)
NZ (1) NZ253409A (de)
WO (1) WO1993025168A1 (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4429667C2 (de) * 1994-08-20 1996-07-11 Lohmann Therapie Syst Lts Estradiol-TTS mit wasserbindenden Zusätzen und Verfahren zu seiner Herstellung
US5601839A (en) * 1995-04-26 1997-02-11 Theratech, Inc. Triacetin as a penetration enhancer for transdermal delivery of a basic drug
DE19517145C2 (de) * 1995-05-10 2000-02-24 Hexal Pharmaforschung Gmbh Transdermales therapeutisches System (TTS) zur Verabreichung von Testosteron
US6572879B1 (en) * 1995-06-07 2003-06-03 Alza Corporation Formulations for transdermal delivery of pergolide
DE69630918T2 (de) * 1995-06-09 2004-10-28 Hisamitsu Pharmaceutical Co., Inc., Tosu Matrix für Iontophorese
CA2208336A1 (en) * 1996-06-20 1997-12-20 Hisamitsu Pharmaceuticals Co., Inc. A device structure for iontophoresis
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
IT1294748B1 (it) 1997-09-17 1999-04-12 Permatec Tech Ag Formulazione per un dispositivo transdermico
IL136042A (en) * 1997-11-10 2005-12-18 Cellegy Pharma Inc Alcohol-containing composition for topical application
DE10019311A1 (de) * 2000-04-19 2001-10-31 Lohmann Therapie Syst Lts Transdermale therapuetische Systeme zur Applikation von Moxonidin
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US20030139384A1 (en) * 2000-08-30 2003-07-24 Dudley Robert E. Method for treating erectile dysfunction and increasing libido in men
PL205279B1 (pl) * 2000-08-30 2010-03-31 Besins International Lab Zastosowanie żelu hydroalkoholowego zawierającego testosteron i zestaw do leczenia zaburzenia erekcji
EA009024B1 (ru) 2002-06-25 2007-10-26 АКРУКС ДиДиЭс ПиТиУай ЭлТиДи Фармацевтическая композиция для чрескожной доставки активного агента (варианты)
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
ES2532906T5 (es) 2002-10-25 2022-03-23 Foamix Pharmaceuticals Ltd Espuma cosmética y farmacéutica
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US9668972B2 (en) 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
JO2492B1 (en) * 2003-04-28 2009-10-05 شيرينج ايه جي A pharmaceutical formula in the form of aqueous gel for the skin use of its active ingredients
US7879357B2 (en) 2003-04-28 2011-02-01 Bayer Schering Pharma Ag Pharmaceutical composition in the form of a hydrogel for transdermal administration of active ingredients
CN102091079B (zh) 2005-06-03 2014-03-12 艾克若克斯Dds有限公司 用于透皮给药的方法和组合物
US8147815B2 (en) 2005-12-16 2012-04-03 Celmatrix Corporation Topical administration carrier composition and therapeutic formulations comprising same
US20080260655A1 (en) 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
KR101301116B1 (ko) 2007-01-11 2013-09-03 애크럭스 디디에스 피티와이 리미티드 분산 기구
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
FR2924942B1 (fr) * 2007-12-14 2012-06-15 Pf Medicament Compositions pharmaceutiques transcutanees contenant une hormone steroidienne
CA2760186C (en) 2009-04-28 2019-10-29 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
DK2952191T3 (en) 2009-06-12 2018-12-10 Sunovion Pharmaceuticals Inc Sublingual apomorphine
CA2769625C (en) 2009-07-29 2017-04-11 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US8871184B2 (en) 2009-10-02 2014-10-28 Foamix Ltd. Topical tetracycline compositions
CA3115378A1 (en) 2010-12-16 2012-06-21 Sunovion Pharmaceuticals Inc. Sublingual films comprising apomorphine and an organic base
WO2012115222A1 (ja) * 2011-02-25 2012-08-30 久光製薬株式会社 経皮または経粘膜投与のためのアジュバントおよびこれを含む医薬製剤
WO2015064710A1 (ja) 2013-10-31 2015-05-07 久光製薬株式会社 アジュバント組成物、これを含むアジュバント製剤、及びキット
USD750788S1 (en) 2013-11-26 2016-03-01 Acrux Dds Pty Ltd Topical spreading applicator
USD749225S1 (en) 2013-11-26 2016-02-09 Acrux Dds Pty Ltd Topical spreading applicator
US8785426B1 (en) 2013-12-13 2014-07-22 Upsher-Smith Laboratories, Inc. Testosterone gel compositions and related methods
EP3285771A4 (de) 2015-04-21 2018-12-05 Sunovion Pharmaceuticals Inc. Verfahren zur behandlung von morbus parkinson durch verabreichung von apomorphin an eine mundschleimhaut
CA2978573A1 (en) 2016-09-08 2018-03-08 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
US9962444B2 (en) 2016-09-27 2018-05-08 Shane Malek Pharmacokinetically extended action topical hair growth formulation, and administration method

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2920500A1 (de) * 1979-05-21 1980-11-27 Boehringer Sohn Ingelheim Pharmazeutische zubereitung in form eines polyacrylatfilmes
JPS6272611A (ja) * 1985-09-27 1987-04-03 Kao Corp 皮膚外用剤
US5059189A (en) * 1987-09-08 1991-10-22 E. R. Squibb & Sons, Inc. Method of preparing adhesive dressings containing a pharmaceutically active ingredient
US4855294A (en) * 1988-09-06 1989-08-08 Theratech, Inc. Method for reducing skin irritation associated with drug/penetration enhancer compositions
GB9016056D0 (en) * 1990-07-21 1990-09-05 Chatfield Pharmaceuticals Limi Transdermal medicine delivery devices
DE4210165A1 (de) * 1991-07-30 1993-02-04 Schering Ag Transdermale therapeutische systeme
EP0612253A4 (de) * 1991-11-12 1995-08-09 Nepera Inc Anklebenok hydrogele mit verlängerter lebensdauer und verfahren zu ihrer herstellung.

Also Published As

Publication number Publication date
EP0644746A1 (de) 1995-03-29
HUT71521A (en) 1995-12-28
HU221598B (hu) 2002-11-28
CA2135925C (en) 2001-04-10
CA2135925A1 (en) 1993-12-23
EP0644746B1 (de) 1999-09-15
KR950701508A (ko) 1995-04-28
EP0644746A4 (de) 1995-09-13
WO1993025168A1 (en) 1993-12-23
GR3031246T3 (en) 1999-12-31
ATE184473T1 (de) 1999-10-15
NZ253409A (en) 1996-09-25
DE69326461T2 (de) 2000-05-04
ES2137993T3 (es) 2000-01-01
JPH08501529A (ja) 1996-02-20
AU4369493A (en) 1994-01-04
DK0644746T3 (da) 1999-12-20
AU677206B2 (en) 1997-04-17
HU9403555D0 (en) 1995-02-28

Similar Documents

Publication Publication Date Title
DE69326461D1 (de) Verwendung von glyzerin zur dämpfung der transdermalen arzneimittelverabreichung
US5614211A (en) Oxybutynin transdermal device having decreased delamination
PT922453E (pt) Preparacao do tipo de absorcao percutanea contendo tulobuterol
NZ306249A (en) matrix patch containing triacetin as a transdermal pentration enhancer
ZA944608B (en) Incorporating poly-N-vinyl amide in a transdermal system
BR9713492A (pt) ésteres de ácido graxo de ácido glicólico e seus sais como realçadores de permeação
ATE89755T1 (de) Vorrichtung zur transdermalen applikation von medikamenten.
LU91972I2 (fr) Fentanyl et applicateur-doseur
DE69637061D1 (de) Neue formulierungen zur transdermalen verabreichung von pergolid
WO1998037872A3 (en) Transdermal drug delivery system for the administration of tamsulosin, and related compositions and methods of use
DK626484D0 (da) Systemer til afgivelse af virksomme stoffer
NZ332746A (en) Transdermal propentofylline compositions for the treatment of Alzheimer's disease
DE69735656D1 (de) Neue Formulierungen zur transdermale Verabreichung von Fluoxetin
KR850700218A (ko) 약학 조성물
EP1125578A4 (de) Bandmaterial zur transkutanen aufnahme
DK0957981T3 (da) Rersorvoirer til aflevering af lægemidler ved elektrotransport, indeholdende inerte fyldmaterialer
JPS6468316A (en) External plaster containing salbutamol
ATE253910T1 (de) Transdermale verabreichung von lasofoxifen
KR970705381A (ko) 흡수성 첨가제를 함유하는 에스트라디올 트랜스더멀 치료 시스템
KR20000029523A (ko) 치매치료및(또는)예방용제제
Hollingsbee et al. The effect of a hydrocolloid dermatological patch (Actiderm) in potentiating the skin blanching activity of triamcinolone acetonide
RU94010496A (ru) Ноотропное средство и лекарственный состав ноотропного средства
TWI243689B (en) Transdermal patch using hydrophilic polymer as matrix

Legal Events

Date Code Title Description
8364 No opposition during term of opposition